OR WAIT null SECS
© 2021 MJH Life Sciences and Formulary Watch. All rights reserved.
© 2021 MJH Life Sciences™ and Formulary Watch. All rights reserved.
July 28, 2021
The agency has stopped enrollment in all ongoing trials.
July 23, 2021
The June 30 approval meets an unmet need in this cancer.
July 20, 2021
Wynzora is a cream-based, fixed dose combination of calcipotriene and betamethasone for topical treatment of psoriasis.
July 15, 2021
Several large payers are waiting on results from the National Coverage Determination.